377 filings
Page 13 of 19
6-K
9yg8ci
27 Jun 16
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
3b10sgdzac
21 Jun 16
Current report (foreign)
12:00am
CT ORDER
skx2wp
16 Jun 16
Confidential treatment order
12:00am
6-K
ah4p7 xw48
13 May 16
Current report (foreign)
12:00am
6-K
lw27lmpayypl3qxcssnz
5 May 16
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
12:00am
6-K
it9 w5dqzb
25 Apr 16
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
12:00am
6-K
6841rpublxq
11 Apr 16
Current report (foreign)
12:00am
6-K
puvttyz71e37 40uaeqi
1 Apr 16
Current report (foreign)
12:00am
6-K
qx4nz9d
14 Mar 16
Current report (foreign)
12:00am
6-K
9vlhmzh72 bp
19 Feb 16
Current report (foreign)
12:00am
SC 13G/A
xm3qgxki1l53 h4g020e
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
iqiu9lkqi2qeohy
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
kr7h 6mhgmusy2tg
12 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
iieovdmhus3akkd lzs
11 Feb 16
Beneficial ownership report (amended)
12:00am
6-K
ppdbi8khlvzb k9lqq
10 Feb 16
GW Pharmaceuticals plc Reports First Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
d3w tw07o3c
29 Dec 15
Current report (foreign)
12:00am
6-K
39axfvkr3 8mff7
28 Dec 15
Current report (foreign)
12:00am
6-K
c811hbezgwsaay wo3
22 Dec 15
Current report (foreign)
12:00am
6-K
ln8uwlx
7 Dec 15
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2015 Financial Results and Operational Progress
12:00am